Healthcare

HB 165 amends Pennsylvania's abortion law to require pain relief medication for fetuses over 15 weeks' gestation during abortion procedures, directly affecting abortion providers performing such procedures. The bill adds a new provision (Section 3204(b.1)) stating that pain relief medication must be administered prior to the procedure unless the physician knows the pregnant person has an adverse reaction to it or a medical emergency prevents timely administration. This change applies specifically to abortions at or beyond 15 weeks' gestation. The law would take effect 60 days after enactment. It focuses on procedural requirements for medical care during abortion, not on restricting access.

HB 803 requires Pennsylvania high schools (grades 9-12) to maintain opioid antagonists like naloxone (Narcan) on-site and train staff to use them during suspected overdose emergencies. Schools must develop a policy within 60 days with the Department of Education, detailing safe storage, administration procedures, and mandatory hospital transport after use. Trained staff, including nurses or teachers, can administer the medication in good faith without facing legal liability, criminal charges, or professional penalties. This law directly affects all public, charter, private, and nonpublic high schools in Pennsylvania, aiming to improve emergency response to opioid overdoses among students and staff.

HB 1033 prohibits healthcare providers from performing gender transition procedures on minors under 18, including surgeries, cross-sex hormones, and puberty blockers. It also requires government health programs (like Medicaid) and health insurance policies to stop covering these procedures for minors. The bill defines "gender transition procedures" to include genital/nongenital surgeries, cross-sex hormones, and puberty blockers. Individuals aged 18 or older are not affected by the ban and may continue receiving such care.